In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Vor Biopharma Inc (NASDAQ: VOR) was $11.67 for the day, up 10.30% from the previous closing price of $10.58. In other words, the price has increased by $10.30 from its previous closing price. On the day, 1.4 million shares were traded. VOR stock price reached its highest trading level at $11.7 during the session, while it also had its lowest trading level at $10.29.
Ratios:
Our analysis of VOR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.16 and its Current Ratio is at 9.16.
On December 09, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $43.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 29 ’25 when RA CAPITAL MANAGEMENT, L.P. sold 251,518 shares for $25.22 per share. The transaction valued at 6,343,284 led to the insider holds 804,231 shares of the business.
RA CAPITAL MANAGEMENT, L.P. sold 124,311 shares of VOR for $3,408,230 on Oct 28 ’25. The Director now owns 1,055,749 shares after completing the transaction at $27.42 per share. On Oct 30 ’25, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, sold 24,579 shares for $25.12 each. As a result, the insider received 617,424 and left with 779,652 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VOR now has a Market Capitalization of 255697072 and an Enterprise Value of -45910948.
Stock Price History:
The Beta on a monthly basis for VOR is 2.03, which has changed by -0.6754601 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, VOR has reached a high of $65.80, while it has fallen to a 52-week low of $2.62. The 50-Day Moving Average of the stock is -14.63%, while the 200-Day Moving Average is calculated to be -47.67%.
Shares Statistics:
VOR traded an average of 1.66M shares per day over the past three months and 1049050 shares per day over the past ten days. A total of 21.91M shares are outstanding, with a floating share count of 17.36M. Insiders hold about 20.77% of the company’s shares, while institutions hold 42.16% stake in the company. Shares short for VOR as of 1765756800 were 1943561 with a Short Ratio of 1.17, compared to 1763078400 on 294571. Therefore, it implies a Short% of Shares Outstanding of 1943561 and a Short% of Float of 10.8100004.
Earnings Estimates
The market rating for Vor Biopharma Inc (VOR) is a result of the insights provided by 4.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$1.08, with high estimates of -$0.29 and low estimates of -$1.65.
Analysts are recommending an EPS of between -$35.21 and -$135.55 for the fiscal current year, implying an average EPS of -$96.97. EPS for the following year is -$4.79, with 4.0 analysts recommending between -$1.39 and -$7.66.
